SPDR S&P Biotech ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $8.36 B.
Over the past 12 months, SPDR S&P Biotech ETF recorded a return of 77.50%, with its price trading between $75.13 and $135.37 during the same period.
The ETF is traded under the ticker XBI.